Growth Strategies Case Study

Case Title:

Sanofi-Aventis: Jean Francois Dehecq's Growth Strategies

Abstract:
The hostile takeover of Aventis by Sanofi-Synthelabo in May 2004, resulted in the formation of Sanofi-Aventis, the world's third largest pharmaceutical company. Jean Francois Dehecq, former chairman of Sanofi-Synthelabo and the man behind the acquisition has, since then, driven the growth of Sanofi-Aventis by focusing on a multicultural research model and working in small groups rather than committees that he believes are often mired in bureaucracy.

Pedagogical Objectives:

• To highlight the factors leading to the acquisition of Aventis
• To discuss the growth strategies adopted by Dehecq for Sanofi-Aventis amidst numerous challenges being faced by the global pharmaceutical industry.

Keywords : Sanofi; Aventis; Global pharmaceutical industry; Growth strategy; Europe; Takeover; Acquisition; Jean Francois Dehecq; Decision making; Research and development; Synergy; Growth Strategies Case Study; Merger

Contents : 
Jean Francois Dehecq: Piloting the Hostile Takeover of Aventis
Jean Francois Dehecq
Dehecq’s Growth Prescription for Sanofi Aventis
Dehecq’s Decision-Making Style
Beyond the US: Sanofi-Aventis Finds Strength in a Multicultural Research Model
Top 10 Pharmaceutical Companies
Size of Sales Team in USA
Sanofi-Aventis’ Top 10 Products